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doi:10.1016/j.jds.2012.05.010Abstract Background/purpose: The purpose of this study was to determine the prevalence
of obstructive sleep apnea (OSA) in patients with squamous cell carcinoma (SSC) of the tongue
after primary surgical resection and to correlate the presence of OSA with the occurrence of
obstructive apnea in this patient population.
Materials and methods: This was a retrospective study of 26 Taiwanese patients, 24 males and
two females, aged 37e71 years, after surgical resection of SSC of the tongue. Patients who had
a follow-up after treatment of 6 months to 11 years were eligible for inclusion. During the post-
treatment period, the occurrence of OSA was determined in these patients. Overnight poly-
somnography (PSG) was used to determine the apneaehypopnea index (AHI). Patients were
considered to have OSA if the AHI value was >5.
Results: Patients with an AHI value of <5 showed a mean body mass index (BMI) of 22.8 kg/m2,
while those with an AHI value of >5 showed a mean BMI of 28.3 kg/m2. The BMI distribution
between patients with AHI value of <5 and those with AHI values of >5 was statistically signif-
icant (PZ 0.018). Using the definition of clinically significant sleep apnea as AHI > 5, 14 of 26
patients (53.85%) had clinical OSA. The OSA and non-OSA groups showed no statistical signifi-
cance in terms of age, tumor size, tongue ablation, neck dissection [method?], or wound
reconstruction methods.
Conclusion: Incidence of OSA in the patient population with SSC of the tongue was found to be
significantly higher than that in the general population. The limitations of this study were thef Stomatology of College of Oral Medicine, Chung Shan Medical University, No. 110, Sec. 1,
n.
w (M.-Y. Chou).
iation for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
246 M.-Y. Chan et alrelatively small patient sample size and no presurgical PSG record being obtained from the
patients to compare the sleep quality before and after cancer therapy.
Copyright ª 2012, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.Introduction
Obstructive sleep apnea (OSA) is a chronic condition char-
acterized by frequent episodes of upper airway collapse
during sleep. It is associated with severe daytime hyper-
somnolence, cardiovascular diseases such as systemic
hypertension and arrhythmias, and automobile accidents,
thereby resulting in significant morbidity and mortality.
The prevalence of OSA is approximately 2% in women and
4% in men in the general population.1 Furthermore, a study
of sleep-disordered breathing (SDB) using full poly-
somnography (PSG) demonstrated a high prevalence of OSA
syndrome (OSAS) of 8.8% among Chinese middle-aged male
office-based workers in Hong Kong [apneaehypopnea index
(AHI) of 5 plus excessive daytime sleepiness].2
Factors that increase the vulnerability of OSA include
age, gender, obesity, family history, menopause, craniofa-
cial abnormalities, and certain health behaviors such as
cigarette smoking and alcohol abuse.1,3 Although cranio-
facial abnormalities have an effect on patients with OSA,
these significantly vary among patients with (1) enlarged
soft tissues such as the tongue base and palate,4,5 (2) nar-
rowing of the pharyngeal space due to anatomic abnor-
malities,6,7 and (3) loss of function of the pharyngeal space
due to anatomic abnormalities.8 Thus, patients who were
successfully treated for head and neck cancers often have
a partially obstructed upper airway, which is functional
during the day but collapses during sleep.9,10 Some case
reports of head and neck cancers also suggested that these
patients may subsequently develop OSA following either
surgical or radiation treatment.11e15 However, since the
head and neck region has broad anatomical coverage and
includes the lips, oral cavity, nasal cavity, paranasal
sinuses, pharynx, and larynx, these case reports did not
pinpoint the specific anatomical area that might influence
the development of OSA.
In Taiwan, oral cancer is the fourth predominant cancer
among males, while the tongue region is one of the high-
prevalence areas affected by oral squamous cell carcinoma
(SSC). Most patients with surgically treated tongue cancer
were also documented to have a narrow upper airway with
a high incidence of OSA.16 Narrowing of the upper airway as
a result of surgery may be due to immobile and bulky flap
reconstructions, altered suprahyoid and pharyngeal
musculature, soft-tissue fibrosis, etc.17 Theoretically,
radiotherapy may have both beneficial and detrimental
effects on the upper airway. In some cases, radiotherapy
may cause tissue scarring that contracts and narrows the
airway, thereby causing OSA to develop. In other cases,
radiation may have a beneficial effect of tightening
redundant soft tissue in the upper airway or reducing
excessive tongue base tissue, thereby decreasing the like-
lihood of OSA.8Literature reviews seldom reported correlations or
prevalence of OSA after tongue-cancer surgery. This
preliminary pilot study was initiated to determine the
prevalence of OSA in a select group of patients with primary
SSC of the tongue who underwent resection with different
reconstruction and/or radiotherapeutic techniques using
PSG and to compare them with the general population.
Materials and methods
Participants
This was a retrospective cross-sectional study of the prev-
alence of patients with sleep apnea who suffered from
primary SSC of the tongue and had been treated with
ablation surgery. Patients with cancer that involved other
areas such as the pharynx or larynx were excluded from the
study. Furthermore, patients who underwent a total
laryngectomy, those who were breathing with the assis-
tance of a tracheotomy/tracheostomy, or those with
obstructive pulmonary disease or a history of OSA prior to
the operation were not included in the study.
Twenty-six patients who underwent surgery with or
without radiotherapy of the tongue SSC were recruited
from the Division of Oral and Maxillofacial Surgery of Tai-
chung Veterans General Hospital. Data were collected
during JanuaryeApril 2009. Types of tongue surgery
included wide excision and a hemiglossectomy to a nearly
total glossectomy. The ablated tongue was reconstructed
with a skin graft, pedicle, or free flap, while neck surgeries
included suprahyoid, modified, and radical neck dissection.
Patients with post-treatment follow-up of 6 months to 11
years and who were free of any residual or recurrent
disease were eligible for inclusion. The following variables
were recorded for each participant: age (years), gender,
weight (kg), body height (cm), BMI (defined as the patient’s
weight divided by the square of the patient’s height; kg/
m2), substance use (alcohol, smoking, or betel quid chew-
ing), tumor size, glossectomy, neck dissection, recon-
struction, and radiotherapy (Tables 1 and 2).
Sleep studies
In the post-treatment period, a sleep study was performed
using overnight PSG, including electroencephalography,
electrocardiography, electroculography, submental elec-
tromyography, airflow, nasal and oral breathing monitored
with a thermocouple, chest and stomach breathing move-
ments monitored with a pressure-sensitive belt, body
movements, blood saturation monitored with a pulse oxi-
meter, and loudness of snoring monitored with a decibel
meter at a distance of 1m.18 PSG data were downloaded into
Table 1 Baseline characteristics and PSG results of patients.
Participant Gender Age BMI Lowest
SpO2
Obstructive
apnea
Hypopnea AHI Tumor
size
(cm)
Glossectomy Neck
dissection
Reconstruction Radio-
therapy
1 Male 32 23.94 93 0 4 0.6 2 Partial Suprahyoid STSG 0
2 Male 52 29.24 91 0 1 0.7 3 Partial Nil STSG 0
3 Male 50 27.12 90 3 0 4.2 2 Partial Radical STSG 0
4 Male 32 20.93 93 0 0 0 2 Partial Suprahyoid PMMC 1
5 Male 60 22.50 94 0 0 0 4 Partial Radical PMMC 1
6 Male 71 19.14 90 0 5 1 3 Hemi Radical and
suprahyoid
STSG 1
7 Male 56 24.57 91 9 8 4 2 Hemi Suprahyoid Free
flap
1
8 Male 59 20.08 93 1 14 3 1 Partial Radical and
suprahyoid
STSG 1
9 Male 47 22.57 91 0 5 0 2 Hemi Suprahyoid STSG 1
10 Male 44 18.59 95 0 1 0 3 Hemi Radical STSG 1
11 Male 49 20.03 93 0 0 0 3 Hemi Radical STSG 1
12 Male 48 24.78 90 5 7 2.6 2 Partial Suprahyoid STSG 1
13 Male 52 22.53 90 6 31 5.8 1 Partial Nil STSG 0
14 Male 59 26.58 85 6 0 5.9 1 Partial Radical PMMC 0
15 Female 40 24.03 90 5 12 7.8 3 Hemi Nil STSG 0
16 Male 42 24.45 84 6 54 10.6 1 Partial Radical STSG 0
17 Male 46 26.21 86 1 32 5.8 3 Partial Suprahyoid STSG 1
18 Male 49 23.99 90 11 27 10 2 Partial Radical and
suprahyoid
Free
flap
1
19 Male 56 27.13 86 9 67 14.8 4 Partial Radical STSG 1
20 Male 54 28.46 72 0 148 25.6 3 Hemi Suprahyoid Free
flap
1
21 Male 66 29.67 80 64 113 44.4 4 Hemi Nil STSG 1
22 Male 48 29.41 84 4 120 24.1 3 Partial Radical Free
flap
0
23 Male 50 36.75 80 5 157 27.1 3 Partial Radical STSG 0
24 Male 71 28.29 83 3 36 8.2 5 Hemi Suprahyoid STSG 1
25 Male 61 24.88 89 43 13 11.8 4 Hemi Radical Free
flap
1
26 Female 59 29.23 88 26 56 15 4 Total Bilateral
modified
Free
flap
1
AHI Z apneaehypopnea index; BMI Z body mass index; PMMC = pectoralis major myocutaneous flap; SpO2 Z pulse oximetry oxygen
saturation; STSG = split thickness skin graft.
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manually scored. An abnormal breathing event (obstructive
apnea) during objectively measured sleep was defined
according to commonly used clinical criteria of a cessation of
airflow for at least 10 seconds. The event was obstructive if,
during the apnea, there was an effort to breathe. An
abnormal respiratory event (hypopnea) was defined as at
least a 30% reduction in the thoracoabdominal movement or
airflow compared to the baseline lasting for at least 10
seconds,with4%oxygendesaturation. Theaveragenumber
of episodes of apnea and hypopnea per hour of sleep (AHI)
was calculated as a summary measurement of OSA.1 Patients
were considered to have OSA if the AHI value was >5.17
Data analysis
Traditional statistical analyses using c2and Fisher exact
tests were used to compare the test results of tongue-cancer patients with those of OSA sufferers in a normal
population. All analyses were done with statistical software
(Statistical Package for the Social Sciences, ver. 11.0 for
Windows; SPSS, Chicago, IL, USA).Results
There were 26 Taiwanese patients (24 males and two
females) with SSC of the tongue after surgical resection
who participated in this study. Their ages ranged from 32 to
71 (mean, 52) years, and BMI from 18.9 to 36.75 (average,
25.2) kg/m2. Fifteen of 26 patients had a BMI of <25
(average, 22.5) kg/m2, while the remaining 11 patients had
a BMI of >25 (average, 28.9) kg/m2 (Table 1). In the group
(n Z 12) with an AHI of <5, the mean BMI was
22.8  3.3 kg/m2, while in the group (nZ 14) with an AHI of
>5, the mean of BMI was 26.3  3.8 kg/m2. The BMI
Table 2 Correction of OSA with baseline data, oral habits, and treatment.
AHI ＜ 5 (n Z 12) AHI  5 (n Z 14) P
Median 25th percentile 75th percentile Median 25th percentile 75th percentile
Age 49.50 44.75 58.25 57.50 49.75 61.25 0.085
BMI 22.54 20.04 24.72 25.86 23.33 28.52 0.017
Obstructive apnea 0.00 0.00 2.50 6.00 3.75 14.75 0.001
Hypopnea 2.50 0.00 6.50 45.00 23.50 114.75 <0.001
Tumor size 2.50 2.00 3.00 3.25 1.88 4.00 0.274
n (%) n (%)
Alcoholic drinking
No 6 (54.5) 6 (60.0) 1.000
Yes 5 (45.5) 4 (40.0)
Betel nut chewing
No 2 (18.2) 3 (30.0) 0.635
Yes 9 (81.8) 7 (70.0)
Cigarette smoking
No 3 (27.3) 2 (20.0) 1.000
Yes 8 (72.7) 8 (80.0)
Radiotherapy
No 3 (25.0) 6 (42.9) 0.429
Yes 9 (75.0) 8 (57.1)
Neck operation
No 1 (8.3) 3 (21.4) 0.598
Yes 11 (91.7) 11 (78.6)
ManneWhitney U test, significant at P < 0.05.
AHI Z apneaehypopnea index; BMI Z body mass index; OSA Z obstructive sleep apnea (OSA).
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with an AHI of >5 was statistically significant (P Z 0.018).
The AHI ranged from 0 to 44.4 (average, 8.96). Using the
definition of clinically significant sleep apnea as an AHI of
>5 or a minimum oxygen desaturation of <90%, 14 of 26
patients (53.85%) were found to have clinical OSA. The
lowest oxygen saturation found in this study was 72%. As to
the age parameter, the group with an AHI of <5 had a mean
age of 50 years, and that with an AHI of >5 had a mean age
of about 57 years, which was not statistically significant
(P Z 0.085) (Tables 1 and 2).
Themean size of the SSC primary tumor of the tonguewas
about 2.7 cm in diameter (Table 1). Therewas no statistically
significant difference between the group with an AHI of <5
and that with an AHI of >5 (PZ 0.274). Among all patients,
85% underwent neck dissection. Using different neck
dissection methods in treating the tongue cancer revealed
no statistical significance (P Z 0.598) (Table 1). Seventeen
of 26 patients (65.4%) received radiation therapy; eight
(47.06%) of those patients had an AHI of >5. In the non-
radiation therapy group, six of nine (66.7%) patients had an
AHI of>5, which was not statistically significant (PZ 0.429)
(Table 1). The OSA and non-OSA groups also showed no
statistically significant differences in terms of tongue abla-
tion or wound reconstruction methods.Discussion
The prevalence of OSA in patients with SSC of the tongue
was 53.85% and was determined to be significantly higher
than that of the general population (3e7% for adult menand 2e5% for adult women).1 It was also 6.1 times higher
than that of male Chinese middle-aged office-based
workers in Hong Kong with OSAS (AHI 5 and excessive
daytime sleepiness) at 8.8%.2 This clearly shows that the
incidence of OSA in tongue-cancer patients is extremely
high compared to that of the general population. In a study
of 16 tongue-cancer patients, only one was diagnosed with
OSA.17 The prevalence of OSA of tongue-carcinoma patients
after treatment in this study was also much higher than
that in studies conducted in other countries.
However, OSA and non-OSA patients showed no statisti-
cally significant differences in terms of age, snoring index,
tumor size, neck dissection, type of tongue reconstruction,
or response to radiotherapy, but did so for the BMI
(PZ 0.018). In fact, a high BMI was clearly demonstrated to
be a significant risk factor for OSA (Tables 1 and 2). A higher
BMI (26.3  3.8 kg/m2) was more frequently seen in the
tongue-cancer patients with OSA than in non-OSA patients
(22.8  3.3 kg/m2). Since the average BMI in this study
(25.2 kg/m2) was higher than that in the study conducted
by Ip et al2 (23.9 kg/m2), the higher incidence of OSA might
have been due to the higher BMI rather than due to tongue
cancer only.
The incidence of OSA in tongue-cancer patients,
particularly its relationship with the various treatment
modalities, remains unclear and is still poorly defined.
Nevertheless, it is reasonable to assume that patients who
have undergone treatment for tongue cancer with or
without flaps to replace the cancerous tongue tissue may
experience OSA. However, a limitation of this study was
that the patient sample size was insufficient to evaluate
the direct influences of age, snoring index, tumor size,
Tongue cancer and obstructive sleep apnea 249local recurrence, neck lymph node metastasis, neck
dissection, and radiotherapy (radiated vs. nonradiated) on
OSA (Tables 1 and 2). Furthermore, no presurgical PSG was
recorded. Therefore, whether tongue cancer itself or the
consequences of tongue ablation surgery, flap reconstruc-
tion, radiotherapy, or chemotherapy induced or worsened
OSA cannot be answered in this study. It is suggested that
healthcare providers monitor the sleep quality of tongue-
cancer patients before and after cancer therapy.
In this study, the “gold standard” diagnostic test of
overnight PSG is an ideal method for assessing the preva-
lence of OSA in post-treatment tongue-cancer patients.
Moreover, it would be ideal if tongue-cancer patients were
assessed by overnight PSG prior to undergoing treatment,
to determine the preexistence of OSA. Pre- and post-
treatment analyses of OSA in tongue-cancer patients are
required to demonstrate any significant level of association
between the treatment type and the sleep apnea status.
Treatment for tongue cancer has evolved over the past
100 years. Nowadays, aside from continual improvements in
surgical techniques such as tumor resection and free flap
reconstruction, the quality of sleeping well without apnea
should be considered in modern-day cancer therapy. The
identification and treatment of OSA might be important
factors in improving the quality of life of tongue-cancer
patients.
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